Leading Expertise Conducting Exit and Embedded Interviews in the Context of Clinical Trials
High-quality patient experience data has become increasingly important for various stakeholders. Qualitative interviews can be valuable in gaining a wide range of insights from trial participants. In fact, the US Food & Drug Administration (FDA) mentioned exit surveys or embedded qualitative interviews in each of the first four patient-focused drug development documents as ways to collect data directly from patients or caregivers to answer research needs.
Evidera’s patient-centered research experts have industry-leading expertise in conducting exit and embedded interviews to illuminate the patient voice throughout drug development.
